
Meclofenamic acid | CAS:644-62-2
Meclofenamic acid
- 名称:甲氯芬那酸; 甲氯灭酸; 2-[(2,6-二氯-3-甲基苯基)氨基]苯甲酸 | Meclofenamic acid
- CAS号:644-62-2
- 别名:2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid
- 分子式:C14H11Cl2NO2
- 分子量:296.15
- EINESC号:211-419-5
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Multiparametric assay using HepaRG cells for predicting drug-induced liver injury.Takafumi Tomida et al.Toxicology letters, 236(1), 16-24 (2015-05-03)
Resveratrol stereoselectively affected (±)warfarin pharmacokinetics and enhanced the anticoagulation effect.Tse-Yin Huang et al.Scientific reports, 10(1), 15910-15910 (2020-09-29)
Development and validation of X-ray diffraction method for quantitative determination of crystallinity in warfarin sodium products.Akhtar Siddiqui et al.International journal of pharmaceutics, 493(1-2), 1-6 (2015-07-26)
Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry.Ryohei Hamaguchi et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 967, 110-117 (2014-08-03)
Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.Frieder Schlunk et al.Translational stroke research, 6(2), 133-139 (2014-11-27)
Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.Catherine K Chang et al.Journal of vascular surgery, 60(6), 1554-1564 (2014-07-22)
Binding properties of sodium glucose co-transporter-2 inhibitor empagliflozin to human serum albumin: spectroscopic methods and computer simulations.Wenjing Wang et al.Journal of biomolecular structure & dynamics, 38(11), 3178-3187 (2019-08-06)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!